SD Biotechnologies shares on Korea’s KOSDAQ suspended for investor protection

• SD Biotechnologies’ common shares on Korea’s KOSDAQ market were suspended from Oct. 8, 2026, on investor-protection grounds.
• The Korea Exchange ordered the trading halt under KOSDAQ market rules.
• The suspension stays in effect pending a court decision on an injunction request tied to a delisting decision.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SD Biotechnologies Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261007900344), on October 07, 2026, and is solely responsible for the information contained therein.